Jaguar Health, Inc. Announces Reverse Stock Split

Jaguar Health (JAGX) will implement a 1-for-15 reverse stock split of its issued and outstanding common stock on September 17, 2026 to support compliance with Nasdaq listing standards.

Rhea-AI Summary

Jaguar Health (JAGX) will implement a 1-for-15 reverse stock split of its issued and outstanding common stock on September 17, 2026 to support compliance with Nasdaq listing standards.

On the effective date, every fifteen shares of common stock outstanding immediately prior will automatically be reclassified into one share, with no change to par value, and the stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market under the symbol JAGX. The new CUSIP for the post-split common stock is 47010C854. No fractional shares will be issued; stockholders otherwise entitled to a fraction will receive a cash payment in lieu of fractional shares. The reverse split was approved at the April 2026 Special Meeting of Stockholders, as described in a definitive proxy statement filed March 24, 2026. Equiniti Trust Company will act as exchange agent, and holders in street name are not required to take action.

Positive

• 1-for-15 reverse stock split expressly intended to support continued compliance with Nasdaq listing standards

Negative

• Fractional share holders will be cashed out and will not receive post-split fractional shares

News Explained

The scheduled 1-for-15 reverse stock split will reduce each holder’s share count and proportionally raise the per-share price on September 17, 2026; the split itself does not change the company’s value.

Argus 15 min delay

+2.07% vs previous close $0.33 last price 22.6x rel. volume Open Argus

Details

Market Reaction – JAGX

-10.4% Trough in 22 min

$0.27 $0.33 Day Range

$1.66M Market Cap

Following this news, JAGX has gained 2.07%, reflecting a moderate positive market reaction. Argus tracked a trough of -10.4% from its starting point during tracking. Our momentum scanner has triggered 11 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $0.33. Trading volume is exceptionally heavy at 22.6x the average, suggesting very strong buying interest.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

A prior 1-for-35 reverse split was followed by a -27.77% 24-hour reaction; this announcement involve...

Analysis

A prior 1-for-35 reverse split was followed by a -27.77% 24-hour reaction; this announcement involved a different ratio, so the historical record documented prior market response without establishing a forecast.

Key Figures

Reverse split ratio: 1-for-15 Effective date: September 17, 2026

Reverse split ratio

1-for-15

Effective September 17, 2026

Effective date

September 17, 2026

Shares begin trading on a split-adjusted basis

Previous Stock split Reports

2 past events · Latest: Apr 27

Same Type 2 events

1. Apr 27

   Reverse stock split

   24h Move

   -27.8%

   Company announced a 1-for-35 reverse split to address Nasdaq bid-price compliance

2. Mar 18

   Reverse stock split

   24h Move

   -47.8%

   Company announced a 1-for-25 reverse split to maintain Nasdaq listing compliance

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse stock split, cusip number, exchange agent, street name

4 terms

reverse stock split financial

"The Company will effect a reverse stock split of its issued and outstanding"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

cusip number technical

"The new CUSIP number for the Company's Common Stock following the reverse stock split"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

exchange agent financial

"Equiniti Trust Company, LLC is acting as exchange agent for the reverse stock split"

An exchange agent is a third party appointed to handle the practical steps when securities are being swapped, such as during mergers, tender offers, or restructurings. Think of it as a trusted post office that collects old shares, verifies ownership, completes required paperwork and regulatory filings, and delivers the new shares or cash to investors; its efficiency and accuracy affect how quickly and safely investors receive the value they're owed.

street name financial

"Stockholders who hold their shares in brokerage accounts or "street name""

A "street name" is a way that stocks or other financial assets are registered under a broker's name rather than directly in an individual investor's name. This allows for easier buying, selling, and transferring of the assets, much like how a library might hold books on behalf of many readers. For investors, using a street name simplifies transactions and helps maintain privacy, but it also means the broker is the official record holder of ownership.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Reverse split approved at April 2026 Special Meeting of Stockholders

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026

SAN FRANCISCO, CA / ACCESS Newswire / September 15, 2026 / Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock ("Common Stock"), at an exchange ratio of 1-for-15, on Thursday, September 17, 2026 (the "Effective Date") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol "JAGX". The new CUSIP number for the Company's Common Stock following the reverse stock split is 47010C854.

The effectuation of the reverse stock split follows the approval of a proposal submitted to Jaguar stockholders at the Company's April 2026 Special Meeting of Stockholders (the "Special Meeting"). This proposal is described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the Securities and Exchange Commission (the "SEC") on March 24, 2026. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at http://www.sec.gov. The proxy statement is also available on the Company's corporate website.

When the reverse stock split becomes effective, every fifteen (15) shares of the Company's Common Stock immediately prior to the Effective Date shall automatically be reclassified into one (1) share of Common Stock, without any change in the par value per share, and this change will be reflected on Nasdaq's website and other stock quote platforms. No fractional shares will be issued as a result of the reverse stock split. Stockholders who otherwise would be entitled to receive a fractional share in connection with the reverse stock split will receive a cash payment in lieu thereof.

Equiniti Trust Company, LLC is acting as exchange agent for the reverse stock split and will send instructions to stockholders of record who hold stock certificates regarding the exchange of their certificates for post-reverse stock split shares of Common Stock. Stockholders who hold their shares in brokerage accounts or "street name" are not required to take any action to effect the exchange of their shares.

About the Jaguar Health Family of Companies

Jaguar Health, Inc. ("Jaguar") develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal ("GI") disease states. Jaguar family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. focus on the development and commercialization of novel crofelemer powder for oral solution for the treatment of rare and orphan gastrointestinal disorders with intestinal failure, including microvillus inclusion disease and short bowel syndrome. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:

Jaguar Health, visit https://jaguar.health

Napo Pharmaceuticals, visit napopharma.com

Napo Therapeutics, visit napotherapeutics.com

Magdalena Biosciences, visit magdalenabiosciences.com

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that the Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:
hello@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the exact ratio and effective date of Jaguar Health's reverse stock split?

The reverse stock split will be effected at a ratio of 1-for-15, meaning every fifteen shares of common stock will be reclassified into one share. The split becomes effective and shares begin trading on a split-adjusted basis on Thursday, September 17, 2026.

How will fractional shares be handled in Jaguar Health's reverse stock split?

No fractional shares will be issued. Stockholders who would otherwise be entitled to receive a fractional share as a result of the reverse stock split will instead receive a cash payment in lieu of that fractional share.

Do Jaguar Health stockholders need to do anything with their certificates or brokerage accounts?

Equiniti Trust Company, LLC, the exchange agent, will send instructions to stockholders of record who hold physical stock certificates about exchanging them for post-split shares. Stockholders who hold their shares in brokerage accounts or in “street name” are not required to take any action to effect the exchange.

Where can investors find more detailed information about the reverse stock split approval?

Details of the proposal approved at the April 2026 Special Meeting of Stockholders are included in Jaguar Health's definitive proxy statement on Schedule 14A filed with the SEC on March 24, 2026. Copies are available for free at http://www.sec.gov and on the company's corporate website.